Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Chetan V. Vakkalagadda, MD"'
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100603- (2023)
Despite the high activity of selective RET inhibitors in RET-driven NSCLC, resistance eventually develops and there is unmet need to better define therapeutic options for patients. This is a case of a patient initially thought to have no targetable a
Externí odkaz:
https://doaj.org/article/c6d38b4552ad4ca8b91fe7e2a64a4418
